Skip to content
Screener

D&A at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$21.57M-6.8%
UnitedHealth Group logo
UnitedHealth GroupUNH
$1.04B-4.1%
Conduent Incorporated logo
Conduent IncorporatedCNDT
$43M-10.4%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
$8.54M-5.1%
Corvel logo
CorvelCRVL
$8.76M+15.5%
Phreesia logo
PhreesiaPHR
$3.37M+12.9%

Segments

By segment

See full
Reportable Segment$24.8M-1.8%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Costs of services (exclusive of depreciation and amortization of intangible assets shown below)67,66760,823136,747121,259
General and administrative expenses55,38951,118113,21998,086
Depreciation24,79625,26149,97949,807
Amortization of intangible assets85,90885,971171,816171,942
Loss on disposal of leases2521,6892905,006
Loss on disposal of assets5713057480
Total expenses234,069224,992472,108446,580
Operating income23,40916,57830,04826,320

Item 1. Financial Statements

FAQ

What is Claritev Corporation's D&A?
Claritev Corporation (CTEV) reported D&A of $85.91M in Q2 2026.
How has Claritev Corporation's D&A changed year-over-year?
Claritev Corporation's D&A decreased by 0.1% year-over-year, from $85.97M to $85.91M.
What is the long-term trend for Claritev Corporation's D&A?
Over 4 years (2021 to 2025), Claritev Corporation's D&A has grown at a 0.3% compound annual growth rate (CAGR), from $340.21M to $343.76M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Ask your AI about Claritev Corporation's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude